3
Background Drug Information
•Drug: Xenical® (orlistat)
•Therapeutic
Category: lipase inhibitor
•Sponsor: Roche
•Original Market
Approval: April 23, 1999
•Pediatric
Exclusivity Granted: September 12, 2003
•OTC switch (adults
only): February 7, 2007
•Mechanism of action:
inhibits absorption of dietary fats